 |
|
Preirradiation Chemotherapy for Advanced Head and Neck Carcinomas
Lawrence J. Kukla, MD;
Rao V. P. Mantravadi, MD;
Edward L. Applebaum, MD;
William P. McGuire, MD
Arch Otolaryngol. 1984;110(2):78-81.
Abstract
| |
• Twenty-six patients with locally advanced squamous cell carcinoma of the head and neck region were treated with combination chemotherapy (cisplatin, bleomycin sulfate, and vincristine sulfate) prior to radiotherapy (RT). The chemotherapy produced a 65% major response rate, all partial responses. Significant hematologic toxic effects occurred in only two patients and severe renal toxic effects were not seen. Concurrently, 20 additional patients with locally advanced cancers were treated with high-dose RT along. Weight loss at the completion of RT and normal tissue reactions were similar in both groups. Complete tumor resolution occurred in 45% of RT-alone patients and 42% of patients completing combined-modality therapy. No difference in recurrence-free survival was seen. Despite minimal additional morbidity and a high response rate, this preirradiation chemotherapy regimen demonstrated no major impact on complete response rate or on long-term recurrence-free survival.
(Arch Otolaryngol 1984;110:78-81)
Author Affiliations
From the Departments of Medicine (Oncology) (Drs Kukla and McGuire), Radiology (Dr Mantravadi), and Otolaryngology—Head and Neck Surgery (Dr Applebaum), University of Illinois Hospital, Chicago.
Footnotes
Accepted for publication June 27, 1983.
Read before the American Society for Head and Neck Surgery, Palm Springs, Calif, March 11, 1983.
Reprint requests to University of Illinois, Section of Medical Oncology, PO Box 6998, Chicago, IL 60680 (Dr Kukla).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Mitomycin and Fluorouracil With Concomitant Radiotherapy in Head and Neck Cancer
Kaplan et al.
Arch Otolaryngol Head Neck Surg 1985;111:220-222.
ABSTRACT
|
